Results 31 to 40 of about 32,201 (250)
Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India [PDF]
Journal of Clinical and Diagnostic Research, 2014 Neuromyelitis optica (also known as Devic’s disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially affects the optic nerve and spinal cord.
Manish Mittal, Garima Mittal
doaj +1 more source
Frontiers in Immunology, 2021 BackgroundDemyelination diseases are complex puzzles that are not always straightforward to diagnose. Multiple sclerosis and neuromyelitis optica are two that are frequently encountered.
Ke Shang +7 more
doaj +1 more source
The Gut Microbiome in Neuromyelitis Optica. [PDF]
, 2017 Neuromyelitis optica (NMO) is a rare, disabling, sometimes fatal central nervous system inflammatory demyelinating disease that is associated with antibodies ("NMO IgG") that target the water channel protein aquaporin-4 (AQP4) expressed on astrocytes ...
Baranzini, Sergio E +3 more
core +1 more source
The borderland of neuromyelitis optica [PDF]
Practical Neurology, 2009 Neuromyelitis optica (NMO), also known as Devic’s disease, is an emerging clinical and pathological entity originally thought to be a variant of multiple sclerosis. Characterised by episodes of demyelination confined to the optic nerve and spinal cord, the discovery in such patients of antibodies to the aquaporin-4 channel has been largely responsible ...
Matthews, L +3 more
openaire +3 more sources
Neuromyelitis Optica and Skin [PDF]
Dermatology, 2022 Neuromyelitis optica spectrum disorder is characterized by attacks of optic neuritis and/or longitudinally extensive transverse myelitis and the presence of anti-aquaporin-4 autoantibodies. Most relapses of neuromyelitis optica worsen over days and then slowly improve in the weeks or months after the maximum clinical deficit has been reached.
Laurent Misery +2 more
openaire +3 more sources
Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine
Case Reports in Medicine, 2011 Lidocaine unmasks silent symptoms and eases neuropathic pain in multiple sclerosis patients; however, the effects of lidocaine in neuromyelitis optica have never been reported.
Akiyuki Uzawa +4 more
doaj +1 more source
Frontiers in Pediatrics, 2022 Biotinidase deficiency is an autosomal recessive, multiple carboxylase deficiency usually associated with seizures, eczema, hypotonia, visual disturbances, hearing loss, and developmental delays. Only a handful of cases of biotinidase deficiency that had
Muhammad Imran Naseer +7 more
doaj +1 more source
Neuromyelitis optica spectrum disorder in a patient with ankylosing spondylitis: A case report
Clinical Case Reports, 2023 Key Clinical Message Neuromyelitis optica spectrum disorder is an autoimmune disease which tends to have other coexisting autoimmune or connective tissue diseases. However, coexisting with ankylosing spondylitis is rare. Here, we report a 57‐year‐old man
Mehri Salari +2 more
doaj +1 more source
Treatment of Corticosteroid Non-responsive Relapse of Neuromyelitis Optica with Intravenous Gamma Globulin – a Case Report [PDF]
Folia Medica, 2020 We report a case of a patient with a relapse of neuromyelitis optica. The relapse was initially treated with intravenous corticosteroids. A therapy with intravenous gamma globulin was started as there was no symptomatic improvement. The patient responded
Maria Dimitrova, Dobromir Iliev
doaj +3 more sources
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4. [PDF]
, 2017 While it is recognized that aquaporin-4 (AQP4)-specific T cells and antibodies participate in the pathogenesis of neuromyelitis optica (NMO), a human central nervous system (CNS) autoimmune demyelinating disease, creation of an AQP4-targeted model with ...
Cruz-Herranz, Andrés +7 more
core +1 more source